Hugh Penfold has over twenty years experience in the pharmaceuticals and biotechnology industries. He has held international business development positions in large and small companies (Medeva, Amersham, Celltech, Avidex), and in the public sector (British Technology Group). Prior to joining Imperial Innovations in June 2005, Hugh was Business Development Director for a non-profit organisation, MIHR, improving access to healthcare in the developing world through innovative management of intellectual property.
His experience in pharmaceuticals and biotechnology licensing and intellectual property includes small molecule drugs, biopharmaceuticals, vaccines, devices and drug delivery technologies. He has also established several profitable international collaborative ventures with the former Eastern bloc. Hugh's training included undergraduate and postgraduate studies in genetics, and a postdoctoral fellowship studying mammalian cell genetics.